Douglas Scientific, LGC Distribution Agreement
News Aug 11, 2014
Under the terms of this agreement LGC will represent and distribute the existing and future Array Tape laboratory automation platforms in Europe, Middle East and Africa.
The combination of disruptive lab automation and KASP™ genotyping assays and reagents, creates a catalyst, driving laboratory productivity and the efficiencies required in genotyping laboratories today.
“This relationship is more than extending the reach of our individual product offerings. It’s about the alignment of two compelling missions. Douglas Scientific exists to make the world a better place with laboratory innovation and LGC is committed to science for a safer world,” says Darren Cook, Executive Vice President of Business Development and Strategy, Douglas Scientific, “If our combined solution results in more food for a growing population, a safer food supply and environment, and faster and less costly diagnostics, then we’ve achieved something much more powerful than we could have independently.”
Giulio Cerroni, Managing Director, Genomics, LGC, comments, “LGC has a great history of working with many diverse companies, consortiums and researchers globally, to increase the understanding of genetic markers in medical research and plant science. Through this new agreement, LGC and Douglas Scientific will further enhance our combined efforts to enable scientists worldwide to reach their goals of feeding the world, curing the world and protecting the world.”
The Array Tape Platform is comprised of Nexar® liquid handling and assay processing system, Soellex® PCR waterbath, Araya® detection, and the Intellics™ Software Suite. The instrumentation enables end-point reactions in Array Tape with small volume reactions (1.6 μL). Array Tape is a continuous polymer strip, serially embossed with reaction wells in customized volumes and formats. The platform is highly compatible with LGC’s KASP genotyping assays and reagents.
LGC’s high-throughput genomics services, offered from UK, US and German laboratories, utilize their own proprietary sbeadex™ DNA extraction chemistry and laboratory-validated genotyping assays, while also taking advantage of their patented fluorescence-based competitive allele-specific PCR (polymerase chain reaction) technique, KASP.
KASP chemistry is an enabling technology that is utilized to genotype known polymorphisms such as SNPS and InDels in the targeted DNA.
LGC scientists have contributed significantly to the development of new genotyping technologies, making affordable projects accessible to a broad range of customers, independent of project size. To date, they have extracted DNA from over 10 million samples, as well as processed over 1 billion PCR reactions.
The combined technologies offered via this relationship will provide a fast, cost effective, and robust solution for high-throughput genetic analysis that significantly simplifies sample preparation, decreases cost per sample, and increases sample throughput. Together, Douglas Scientific and LGC’s Genomics Division will work with customers in the pharmaceuticals, agricultural biotechnology, food, environment, government, academic, security and sports sectors to achieve excellence in investigative, diagnostic and measurement science and to provide a disruptive and complete solution for any high-throughput laboratories currently using PCR technologies.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.